Authors: FIJNVANDRAAT K BERNTORP E TENCATE JW JOHNSSON H PETERS M SAVIDGE G TENGBORN L SPIRA J STAHL C

Citation: K. Fijnvandraat et al., RECOMBINANT, B-DOMAIN DELETED FACTOR-VIII (R-VIII SQ) - PHARMACOKINETICS AND INITIAL SAFETY ASPECTS IN HEMOPHILIA-A PATIENTS, Thrombosis and haemostasis, 77(2), 1997, pp. 298-302

Authors: LUSHER JM SPIRA J

Citation: Jm. Lusher et J. Spira, SAFETY, EFFICACY AND INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUPS) TREATED EXCLUSIVELY WITH RECOMBINANT B-DOMAIN DELETED F-VIII (RVIII-SQ) - 2.5 STUDY YEARS, Blood, 90(10), 1997, pp. 2664-2664

Authors: LIND P LARSSON K SPIRA J SYDOWBACKMAN M ALMSTEDT A GRAY E SANDBERG H

Citation: P. Lind et al., NOVEL FORMS OF B-DOMAIM-DELETED RECOMBINANT FACTOR-VIII MOLECULES - CONSTRUCTION AND BIOCHEMICAL-CHARACTERIZATION, European journal of biochemistry, 232(1), 1995, pp. 19-27

Authors: SPIRA J

Citation: J. Spira, A B-DOMAIN-DELETED RECOMBINANT FACTOR-VIII CONCENTRATE, Transfusion, 34(8), 1994, pp. 728-728

Authors: SANDBERG H LIND P SPIRA J ALMSTEDT A GRAY E LARSSON K SYDOWBACKMAN M

Citation: H. Sandberg et al., EVALUATION OF VARIOUS RECOMBINANT DELETION DERIVATIVES OF FACTOR-VIII, Thrombosis and haemostasis, 69(6), 1993, pp. 553-553